You are here

EMERGING ENTERPRISE

Developing robotic tools for surgery

EndoMaster hopes to revolutionise how surgeries for gastrointestinal cancer are done through its new non-invasive procedure.

BT_20180903_YCENDOMASTER_3549557.jpg
(From far left) EndoMaster CEO Goh Seow Ping, non-executive chairman Prof Louis Phee, and COO Colin Tan. The company aims to complete clinical trials of the robotic system by 2Q 2019.

Singapore

SPUN out of research from the National University of Singapore and Nanyang Technological University, EndoMaster gives surgeons the tools to remove gastrointestinal cancer tumours without the need for surgical incisions on the body or organ.

In short, it aims to create the...

sentifi.com

Market voices on: